Skip to main content

Advertisement

Log in

Notch signalling in cancer stem cells

  • Educational Series
  • Molecular Targets in Oncology
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

A new theory about the development of solid tumours is emerging from the idea that solid tumours, like normal adult tissues, contain stem cells (called cancer stem cells) and arise from them. Genetic mutations encoding for proteins involved in critical signalling pathways for stem cells such as BMP, Notch, Hedgehog and Wnt would allow stem cells to undergo uncontrolled proliferation and form tumours. Taking into account that cancer stem cells (CSCs) would represent the real driving force behind tumour growth and that they may be drug resistant, new agents that target the above signalling pathways could be more effective than current anti-solid tumour therapies. In the present paper we will review the molecular basis of the Notch signalling pathway. Additionally, we will pay attention to their role in adult stem cell self-renewal, and cell fate specification and differentiation, and we will also review evidence that supports their implication in cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fiúza UM, Arias AM (2007) Cell and molecular biology of Notch. J Endocrinol 194:459–474

    Article  PubMed  Google Scholar 

  2. Ailles LE, Weissman IL (2007) Cancer stem cells in solid tumors. Curr Opin Biotechnol 18:460–466

    Article  PubMed  CAS  Google Scholar 

  3. Bolós V, Grego-Bessa J, de la Pompa JL (2007) Notch signaling in development and cancer. Endocr Rev 28:339–363

    Article  PubMed  Google Scholar 

  4. Schweisguth F (2004) Regulation of notch signaling activity. Curr Biol 14:R129–138

    PubMed  CAS  Google Scholar 

  5. Ehebauer M, Hayward P, Martinez-Arias (2006) Notch signaling pathway. Sci STKE 364:cm7

    Google Scholar 

  6. Katoh M, Katoh M (2007) Notch signaling in gastrointestinal tract. Int J Oncol 30:247–251

    PubMed  CAS  Google Scholar 

  7. Katsube K, Sakamoto K (2005) Notch in vertebrates — molecular aspects of the signal. Int J Dev Biol 49:369–374

    Article  PubMed  CAS  Google Scholar 

  8. Le Borgne R, Bardin A, Schweisguth F (2005) The roles of receptor and ligand endocytosis in regulating Notch signaling. Development 132: 1751–1762

    Article  PubMed  Google Scholar 

  9. Vodovar N, Schweisguth F (2008) Functions of O-fucosyltransferase in Notch trafficking and signaling: towards the end of a controversy? J Biol 7:7

    Article  PubMed  Google Scholar 

  10. Fischer A, Gessler M (2007) Delta-Notch — and then? Protein interactions and proposed modes of repression by Hes and Hey bHLH factors. Nucleic Acids Res 35:4583–4596

    Article  PubMed  CAS  Google Scholar 

  11. Kageyama R, Masamizu Y, Niwa Y (2007) Oscillator mechanism of Notch pathway in the segmentation clock. Dev Dyn 236:1403–1409

    Article  PubMed  CAS  Google Scholar 

  12. Schouwey K, Beermann F (2008) The Notch pathway: hair graying and pigment cell homeostasis. Histol Histopathol 23:609–619

    PubMed  CAS  Google Scholar 

  13. Watt FM, Estrach S, Ambler CA (2008) Epidermal Notch signalling: differentiation, cancer and adhesion. Curr Opin Cell Biol 20:171–179

    Article  PubMed  CAS  Google Scholar 

  14. Niessen K, Karsan A (2007) Notch signaling in the developing cardiovascular system. Am J Physiol Cell Physiol 293:C1–11

    Article  PubMed  CAS  Google Scholar 

  15. Siekmann AF, Covassin L, Lawson ND (2008) Modulation of VEGF signalling output by the Notch pathway. Bioessays 30:303–313

    Article  PubMed  CAS  Google Scholar 

  16. Gridley T (2007) Notch signaling in vascular development and physiology. Development 134: 2709–2718

    Article  PubMed  CAS  Google Scholar 

  17. Chiba S (2006) Notch signaling in stem cell systems. Stem Cells 24:2437–2447

    Article  PubMed  CAS  Google Scholar 

  18. Leong KG, Gao WQ (2008) The Notch pathway in prostate development and cancer. Differentiation 76: 699–716

    Article  PubMed  CAS  Google Scholar 

  19. Koch U, Radtke F (2007) Notch and cancer: a double-edged sword. Cell Mol Life Sci 64:2746–2762

    Article  PubMed  CAS  Google Scholar 

  20. Lai EC (2004) Notch signaling: control of cell communication and cell fate. Development 131:965–973

    Article  PubMed  CAS  Google Scholar 

  21. Lewis J (1998) Notch signalling and the control of cell fate choices in vertebrates. Semin Cell Dev Biol 9:583–589

    Article  PubMed  CAS  Google Scholar 

  22. de Celis JF, Bray S (1997) Feed-back mechanisms affecting Notch activation at the dorsoventral boundary in the Drosophila wing. Development 124:3241–3251

    PubMed  Google Scholar 

  23. Huppert SS, Jacobsen TL, Muskavitch MA (1997) Feedback regulation is central to Delta-Notch signalling required for Drosophila wing vein morphogenesis. Development 124:3283–3291

    PubMed  CAS  Google Scholar 

  24. Eddison M, Le Roux I, Lewis J (2000) Notch signaling in the development of the inner ear: lessons from Drosophila. Proc Natl Acad Sci U S A 97: 11692–11699

    Article  PubMed  CAS  Google Scholar 

  25. Savill NJ, Sherratt JA (2003) Control of epidermal stem cell clusters by Notch-mediated lateral induction. Dev Biol 258:141–153

    Article  PubMed  CAS  Google Scholar 

  26. Nickoloff BJ, Osborne BA, Miele L (2003) Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene 22: 6598–6608

    Article  PubMed  CAS  Google Scholar 

  27. Radtke F, Raj K (2003) The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer 3:756–767

    Article  PubMed  CAS  Google Scholar 

  28. Aster JC (2005) Deregulated NOTCH signaling in acute T-cell lymphoblastic leukemia/lymphoma: new insights, questions, and opportunities. Int J Hematol 82:295–230

    Article  PubMed  CAS  Google Scholar 

  29. Charafe-Jauffret E, Monville F, Ginestier C et al (2008) Cancer stem cells in breast: current opinion and future challenges. Pathobiology 75:75–84

    Article  PubMed  Google Scholar 

  30. Dontu G, Al-Hajj M, Abdallah WM et al (2003) Stem cells in normal breast development and breast cancer. Cell Prolif 36[Suppl 1]:59–72

    Article  Google Scholar 

  31. Dontu G, Jackson KW, McNicholas E et al (2004) Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res 6:R605–R615

    Article  PubMed  CAS  Google Scholar 

  32. Chang JC, Li X, Wong H et al (2007) Therapeutic resistance and tumor-initiation: Molecular pathways involved in breast cancer stem cell self-renewal. J Clin Oncol ASCO Annual Meeting Proceedings (Post-Meeting Edition) 25[Suppl 18]:528

    Google Scholar 

  33. Stylianou S, Clarke RB, Brennan K (2006) Aberrant activation of notch signaling in human breast cancer. Cancer Res 66:1517–1525

    Article  PubMed  CAS  Google Scholar 

  34. Parr C, Watkins G, Jiang WG (2004) The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. Int J Mol Med 14: 779–786

    PubMed  CAS  Google Scholar 

  35. Reedijk M, Odorcic S, Chang L et al (2005) High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res 65:8530–8537

    Article  PubMed  CAS  Google Scholar 

  36. Pece S, Serresi M, Santolini E et al (2004) Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol 167:215–221

    Article  PubMed  CAS  Google Scholar 

  37. Colaluca IN, Tosoni D, Nuciforo P et al (2008) NUMB controls p53 tumour suppressor activity. Nature 451:76–80

    Article  PubMed  CAS  Google Scholar 

  38. Weijzen S, Rizzo P, Braid M et al (2002) Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med 8:979–986

    Article  PubMed  CAS  Google Scholar 

  39. Rizzo P, Miao H, D’souza G et al (2008) Crosstalk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res 68:5226–5235

    Article  PubMed  CAS  Google Scholar 

  40. Osipo C, Patel P, Rizzo P et al (2008) ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor. Oncogene 27:5019–5032

    Article  PubMed  CAS  Google Scholar 

  41. Lee CW, Raskett CM, Prudovsky I, Altieri DC (2008) Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis. Cancer Res 68:5273–5281

    Article  PubMed  CAS  Google Scholar 

  42. Krop IE, Kosh M, Fearen I et al (2006) Phase I pharmacokinetic (PK), and pharmacodynamic (PD) trial of the novel oral Notch inhibitor MK-0752 in patients (pts) with advanced breast cancer (BC) and other solid tumors. ASCO Annual Meeting. Abstract No: 10574

  43. http://clinicaltrials.gov/ct2/show/NCT00645333?intr=%22MK0752%22&rank=2)

  44. van Es JH, Clevers H (2005) Notch and Wnt inhibitors as potential new drugs for intestinal neoplastic disease. Trends Mol Med 11:496–502

    Article  PubMed  Google Scholar 

  45. Sancho E, Batlle E, Clevers H (2004) Signaling pathways in intestinal development and cancer. Annu Rev Cell Dev Biol 20:695–723

    Article  PubMed  CAS  Google Scholar 

  46. van Es JH, van Gijn ME, Riccio O et al (2005) Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 435:959–963

    Article  PubMed  Google Scholar 

  47. Meng RD, Qin L, Shelton CC et al (2008) Use of the Notch signaling pathway to predict disease progression and distant recurrence-free survival in early stage colon cancer. ASCO Annual Meeting. Abstract No: 14500

  48. Akiyoshi T, Nakamura M, Yanai K et al (2008) Gamma-secretase inhibitors enhance taxane-induced mitotic arrest and apoptosis in colon cancer cells. Gastroenterology 134: 131–144

    Article  PubMed  CAS  Google Scholar 

  49. Lim SJ, Fan F, Dallas NA et al (2008) Resistance to oxaliplatin in human intestinal-type gastric cancer cells demonstrates increased migration, invasion and expression of angiogenic factors. ASCO Gastrointestinal Cancer Symposium. Abstract No: 91

  50. Duncan AW, Rattis FM, DiMascio LN et al (2005) Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 6:314–322

    Article  PubMed  CAS  Google Scholar 

  51. Weng AP, Ferrando AA, Lee W et al (2004) Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306:269–271

    Article  PubMed  CAS  Google Scholar 

  52. Aster JC (2005) Deregulated NOTCH signaling in acute T-cell lymphoblastic leukemia/lymphoma: new insights, questions, and opportunities. Int J Hematol 82:295–301

    Article  PubMed  CAS  Google Scholar 

  53. Deangelo DJ, Stone RM, Silverman LB et al (2006) A phase I clinical trial of the notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and other leukemias. ASCO Annual Meeting. Abstract No: 6585

  54. Lowell S, Jones P, Le Roux I et al (2000) Stimulation of human epidermal differentiation by deltanotch signalling at the boundaries of stem-cell clusters. Curr Biol 10:491–500

    Article  PubMed  CAS  Google Scholar 

  55. Rangarajan A, Talora C, Okuyama R et al (2001) Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J 20:3427–3436

    Article  PubMed  CAS  Google Scholar 

  56. Nicolas M, Wolfer A, Raj K et al (2003) Notch1 functions as a tumor suppressor in mouse skin. Nat Genet 33:416–421

    Article  PubMed  CAS  Google Scholar 

  57. Thelu J, Rossio P, Favier B (2002) Notch signalling is linked to epidermal cell differentiation level in basal cell carcinoma, psoriasis and wound healing. BMC Dermatol 2:7

    Article  PubMed  Google Scholar 

  58. Devgan V, Mammucari C, Millar SE et al (2005) p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation. Genes Dev 19:1485–1495

    Article  PubMed  CAS  Google Scholar 

  59. Kolev V, Mandinova A, Guinea-Viniegra J et al (2008) EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer. Nat Cell Biol 10:902–911

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Victoria Bolós.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bolós, V., Blanco, M., Medina, V. et al. Notch signalling in cancer stem cells. Clin Transl Oncol 11, 11–19 (2009). https://doi.org/10.1007/s12094-009-0305-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-009-0305-2

Keywords

Navigation